Dennis Gillings, chairman, chief executive officer and founder of Quintiles Transnational, dedicated the company’s new laboratory in Mumbai, India on Monday.
The opening of the contract research organization’s facility also coincided with the 10th year of doing business in India.
The lab includes support for global and regional clinical trials as well as research, electrocardiogram, interactive voice response and data management services.
"The opening of this new lab in India symbolizes the rapid growth and achievement of our team here, as well as the acceptance of India as a center for clinical research," Gillings said in a statement. "Since establishing an office in Ahmedabad 10 years ago, we have added offices in Mumbai and Bangalore with a full complement of services, expanded our clinical research staff to 750 and have conducted more than 700 global trials across business lines. We also were involved in the training of hundreds of investigators on Good Clinical Practice guidelines and helped put India on the world map for clinical research."
Quintiles also has overseas operations in Europe, South Africa, China and Singapore.